These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10822311)

  • 1. Calcium antagonists, ACE inhibitors, and the risk of cancer in hypertensive patients.
    Grossman E; Messerli FH
    J Hum Hypertens; 2000 May; 14(5):285-6. PubMed ID: 10822311
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium channel blockers, ACE inhibitors, and the risk of cancer in hypertensive patients: a report from the Department of Health Hypertension Care Computing Project (DHCCP).
    Stahl M; Bulpitt CJ; Palmer AJ; Beevers DG; Coles EC; Webster J
    J Hum Hypertens; 2000 May; 14(5):299-304. PubMed ID: 10822315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer risk with calcium-channel-blocker use examined.
    Am J Health Syst Pharm; 1996 Sep; 53(17):1999. PubMed ID: 8870883
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcium-channel blockers and risk of cancer.
    Jick H; Jick S; Derby LE; Vasilakis C; Myers MW; Meier CR
    Lancet; 1997 Feb; 349(9051):525-8. PubMed ID: 9048789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacological basis for the combination of calcium channel antagonists and angiotensin converting enzyme inhibitors in the treatment of hypertension.
    Osswald H; Mühlbauer B
    J Hypertens Suppl; 1995 Aug; 13(2):S21-8. PubMed ID: 8576784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do calcium channel blockers increase the risk of cancer?
    Pahor M; Guralnik JM; Salive ME; Corti MC; Carbonin P; Havlik RJ
    Am J Hypertens; 1996 Jul; 9(7):695-9. PubMed ID: 8806983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCBs vs ACE inhibitors in patients with diabetes.
    Zamorski MA
    J Fam Pract; 1998 Jul; 47(1):12-3. PubMed ID: 9673598
    [No Abstract]   [Full Text] [Related]  

  • 8. Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial.
    Suliburska J; Skrypnik K; Szulińska M; Kupsz J; Markuszewski L; Bogdański P
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30208601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses' health study.
    Michels KB; Rosner BA; Walker AM; Stampfer MJ; Manson JE; Colditz GA; Hennekens CH; Willett WC
    Cancer; 1998 Nov; 83(9):2003-7. PubMed ID: 9806660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Side effects and safety in drug therapy of hypertension].
    Imataka K
    Nihon Rinsho; 1992 May; 50 Suppl():381-7. PubMed ID: 1355134
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old.
    Pahor M; Guralnik JM; Furberg CD; Carbonin P; Havlik R
    Lancet; 1996 Apr; 347(9008):1061-5. PubMed ID: 8602055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of combination therapy with ACE inhibitors and calcium channel blockers in renal protection.
    Locatelli F; Del Vecchio L; Andrulli S; Colzani S
    Kidney Int Suppl; 2002 Dec; (82):S53-60. PubMed ID: 12410856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug treatment of the hypertensive diabetic.
    Kendall MJ; Lewis H; Griffith M; Barnett AH
    J Hum Hypertens; 1988 Mar; 1(4):249-58. PubMed ID: 2906093
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin resistance and hypertension in the elderly. Optimal drug therapy.
    Paolisso G; Gambardella A; Galzerano D; Varricchio M
    Drugs Aging; 1994 May; 4(5):403-9. PubMed ID: 8043942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer.
    Meier CR; Derby LE; Jick SS; Jick H
    Arch Intern Med; 2000 Feb; 160(3):349-53. PubMed ID: 10668837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension.
    Morgan TO; Anderson AI; MacInnis RJ
    Am J Hypertens; 2001 Mar; 14(3):241-7. PubMed ID: 11281235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive medications and risk of community-acquired pneumonia.
    Mukamal KJ; Ghimire S; Pandey R; O'Meara ES; Gautam S
    J Hypertens; 2010 Feb; 28(2):401-5. PubMed ID: 20051911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacokinetic and clinical profiles of angiotensin-converting enzyme inhibitors and calcium antagonists in systemic hypertension.
    Frishman WH
    Am J Cardiol; 1992 Apr; 69(10):17C-25C. PubMed ID: 1546635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of risk of pneumonia associated with use of angiotensin I converting enzyme inhibitors in elderly inpatients.
    Okaishi K; Morimoto S; Fukuo K; Niinobu T; Hata S; Onishi T; Ogihara T
    Am J Hypertens; 1999 Aug; 12(8 Pt 1):778-83. PubMed ID: 10480470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium antagonists and the diabetic patient: a response to recent controversies.
    Poulter NR
    Am J Cardiol; 1998 Nov; 82(9B):40R-41R. PubMed ID: 9822144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.